On October 28th, we handed over an open letter to the Dutch Ministry of Health calling for increased transparency in the pharmaceutical sector. The letter was signed by numerous experts and organizations, including the Dutch Patient Federation and Doctors Without Borders Netherlands. The current lack of transparency is leading to inexplicably high medicine prices, which weigh heavily on healthcare budgets. Early next year we will also present the letter to the Dutch House of Representatives.
News
2/12/2025
Opinion article: Tackle taxes and debt for global health (in Dutch)
In an opinion piece in De Volkskrant, Wemos' expert in health financing, Mariska Meurs explains why a fair international system of taxation and debt relief is in the interests of the health and safety of us all. Read more
